Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 26 Aug 2020 |
2 | Reply to Exam Report (MIS-R) | 23 Nov 2020 |
3 | Authorization Letter | 15 Apr 2023 |
4 | Authorization Letter | 31 May 2023 |
5 | Journal Copy | 17 Nov 2023 |
6 | Certificate | 28 Feb 2024 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 24 Jul 2024 |
1 | EXAMINATION REPORT | 10442348 | 21 Sep 2020 | |
2 | Hearing Notice (Show Cause) | 12624183 | 10 Dec 2021 | |
3 | Hearing Notice (Show Cause) | 12832231 | 17 Jan 2022 | |
4 | Hearing Notice (Show Cause) | 13479343 | 11 May 2022 | |
5 | Hearing Notice (Show Cause) | 14992686 | 22 Mar 2023 | |
6 | Hearing Notice (Show Cause) | 15174486 | 01 May 2023 | |
7 | Tribunal Accepted Notice for : 4625910 | 16014074 | 6189995 | 12 Sep 2023 |
The application for Super bioavailable technology was made on 26 August 2020.
The trademark applicant for Super bioavailable technology is INTAS PHARMACEUTICALS.
Super bioavailable technology is applied in class(es) 35.
Application for Super bioavailable technology is on Registered stage.
Application Id allotted to Super bioavailable technology is 4625910.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Super bioavailable technology filed with the Intellectual property office as a DEVICE.